BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25821559)

  • 21. p300 is involved in formation of the TBP-TFIIA-containing basal transcription complex, TAC.
    Mitsiou DJ; Stunnenberg HG
    EMBO J; 2003 Sep; 22(17):4501-11. PubMed ID: 12941701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TATA-dependent repression of human immunodeficiency virus type-1 transcription by the adenovirus E1A 243R oncoprotein.
    Tsang SX; Morris GF; Lu M; Morris CB
    Oncogene; 1996 Feb; 12(4):819-26. PubMed ID: 8632904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300.
    Lee JS; Galvin KM; See RH; Eckner R; Livingston D; Moran E; Shi Y
    Genes Dev; 1995 May; 9(10):1188-98. PubMed ID: 7758944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription.
    Parker SF; Felzien LK; Perkins ND; Imperiale MJ; Nabel GJ
    J Virol; 1997 Mar; 71(3):2004-12. PubMed ID: 9032332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the Adenovirus Early Gene 1A Transcription-Repression Domain Alone Downregulates HER2 and Results in the Death of Human Breast Cancer Cells Upregulated for the HER2 Proto-Oncogene.
    Loewenstein PM; Green M
    Genes Cancer; 2011 Jul; 2(7):737-44. PubMed ID: 22207899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300.
    Vries RG; Prudenziati M; Zwartjes C; Verlaan M; Kalkhoven E; Zantema A
    EMBO J; 2001 Nov; 20(21):6095-103. PubMed ID: 11689449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
    Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
    J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysosome-dependent p300/FOXP3 degradation and limits Treg cell functions and enhances targeted therapy against cancers.
    Du T; Nagai Y; Xiao Y; Greene MI; Zhang H
    Exp Mol Pathol; 2013 Aug; 95(1):38-45. PubMed ID: 23644046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic functions of SII and p300 in productive activator-dependent transcription of chromatin templates.
    Guermah M; Palhan VB; Tackett AJ; Chait BT; Roeder RG
    Cell; 2006 Apr; 125(2):275-86. PubMed ID: 16630816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ZZ domain of p300 mediates specificity of the adjacent HAT domain for histone H3.
    Zhang Y; Xue Y; Shi J; Ahn J; Mi W; Ali M; Wang X; Klein BJ; Wen H; Li W; Shi X; Kutateladze TG
    Nat Struct Mol Biol; 2018 Sep; 25(9):841-849. PubMed ID: 30150647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc.
    Sankar N; Baluchamy S; Kadeppagari RK; Singhal G; Weitzman S; Thimmapaya B
    Oncogene; 2008 Sep; 27(43):5717-28. PubMed ID: 18542060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity.
    Chakravarti D; Ogryzko V; Kao HY; Nash A; Chen H; Nakatani Y; Evans RM
    Cell; 1999 Feb; 96(3):393-403. PubMed ID: 10025405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells.
    Filon M; Yang B; Purohit TA; Schehr J; Singh A; Bigarella M; Lewis P; Denu J; Lang J; Jarrard DF
    Oncotarget; 2023 Jul; 14():738-746. PubMed ID: 37477521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PLDLS-dependent interaction of E1A with CtBP: regulation of CtBP nuclear localization and transcriptional functions.
    Zhao LJ; Subramanian T; Vijayalingam S; Chinnadurai G
    Oncogene; 2007 Nov; 26(54):7544-51. PubMed ID: 17546044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation.
    Stiehl DP; Fath DM; Liang D; Jiang Y; Sang N
    Cancer Res; 2007 Mar; 67(5):2256-2264. PubMed ID: 17332356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p300 Acetylates JHDM1A to inhibit osteosarcoma carcinogenesis.
    Wang Y; Sun B; Zhang Q; Dong H; Zhang J
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2891-2899. PubMed ID: 31307234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brd4's Bromodomains Mediate Histone H3 Acetylation and Chromatin Remodeling in Pluripotent Cells through P300 and Brg1.
    Wu T; Kamikawa YF; Donohoe ME
    Cell Rep; 2018 Nov; 25(7):1756-1771. PubMed ID: 30428346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A.
    Savelyeva I; Dobbelstein M
    Oncogene; 2011 Feb; 30(7):865-75. PubMed ID: 20935676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylation regulates the differentiation-specific functions of the retinoblastoma protein.
    Nguyen DX; Baglia LA; Huang SM; Baker CM; McCance DJ
    EMBO J; 2004 Apr; 23(7):1609-18. PubMed ID: 15044952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo.
    Li Q; Herrler M; Landsberger N; Kaludov N; Ogryzko VV; Nakatani Y; Wolffe AP
    EMBO J; 1998 Nov; 17(21):6300-15. PubMed ID: 9799238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.